These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7593419)
1. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Walker BR; Connacher AA; Lindsay RM; Webb DJ; Edwards CR J Clin Endocrinol Metab; 1995 Nov; 80(11):3155-9. PubMed ID: 7593419 [TBL] [Abstract][Full Text] [Related]
2. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. Andrews RC; Rooyackers O; Walker BR J Clin Endocrinol Metab; 2003 Jan; 88(1):285-91. PubMed ID: 12519867 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Walker BR; Connacher AA; Webb DJ; Edwards CR Clin Sci (Lond); 1992 Aug; 83(2):171-8. PubMed ID: 1327632 [TBL] [Abstract][Full Text] [Related]
4. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. Andrew R; Smith K; Jones GC; Walker BR J Clin Endocrinol Metab; 2002 Jan; 87(1):277-85. PubMed ID: 11788660 [TBL] [Abstract][Full Text] [Related]
5. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension. Walker BR; Stewart PM; Shackleton CH; Padfield PL; Edwards CR Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136 [TBL] [Abstract][Full Text] [Related]
6. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475 [TBL] [Abstract][Full Text] [Related]
7. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Sandeep TC; Andrew R; Homer NZ; Andrews RC; Smith K; Walker BR Diabetes; 2005 Mar; 54(3):872-9. PubMed ID: 15734867 [TBL] [Abstract][Full Text] [Related]
8. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats. Livingstone DE; Walker BR J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365 [TBL] [Abstract][Full Text] [Related]
10. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Lindsay RS; Lindsay RM; Waddell BJ; Seckl JR Diabetologia; 1996 Nov; 39(11):1299-305. PubMed ID: 8932995 [TBL] [Abstract][Full Text] [Related]
11. Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. Wake DJ; Homer NZ; Andrew R; Walker BR J Clin Endocrinol Metab; 2006 Nov; 91(11):4682-8. PubMed ID: 16954164 [TBL] [Abstract][Full Text] [Related]
12. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism. Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion. Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419 [TBL] [Abstract][Full Text] [Related]
14. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients. Ulick S; Wang JZ; Hanukoglu A; Rösler A J Lab Clin Med; 1993 Dec; 122(6):673-6. PubMed ID: 8245686 [TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man. Stewart PM; Wallace AM; Atherden SM; Shearing CH; Edwards CR Clin Sci (Lond); 1990 Jan; 78(1):49-54. PubMed ID: 2153495 [TBL] [Abstract][Full Text] [Related]
16. Structure and function of the hepatic form of 11 beta-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Moore CC; Mellon SH; Murai J; Siiteri PK; Miller WL Endocrinology; 1993 Jul; 133(1):368-75. PubMed ID: 8319583 [TBL] [Abstract][Full Text] [Related]
17. Enzyme- and mineralocorticoid receptor-controlled electrogenic Na+ absorption in human rectum in vitro. Epple HJ; Schulzke JD; Schmitz H; Fromm M Am J Physiol; 1995 Jul; 269(1 Pt 1):G42-8. PubMed ID: 7631800 [TBL] [Abstract][Full Text] [Related]
18. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. Rauz S; Walker EA; Shackleton CH; Hewison M; Murray PI; Stewart PM Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2037-42. PubMed ID: 11481269 [TBL] [Abstract][Full Text] [Related]
19. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Seckl JR Front Neuroendocrinol; 1997 Jan; 18(1):49-99. PubMed ID: 9000459 [TBL] [Abstract][Full Text] [Related]
20. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues. Stewart PM; Murry BA; Mason JI J Clin Endocrinol Metab; 1994 Jun; 78(6):1529-32. PubMed ID: 8200959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]